• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth

    5/22/25 8:31:00 AM ET
    $DSS
    Containers/Packaging
    Consumer Discretionary
    Get the next $DSS alert in real time by email

    NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating across diverse industries including packaging, real estate, and biomedical innovation, today announced financial results for the first quarter of 2025, highlighting meaningful progress in its financial repositioning and a strong foundation for corporate execution in the coming quarters.

    In a quarter focused on streamlining operations and financial discipline, DSS delivered significant improvements in key financial metrics:

    • 28% Year-Over-Year Revenue Growth: Total revenues rose sharply, fueled by a 30% increase in printed product sales and a nearly doubling of rental income from the company's real estate segment, which grew from $400,000 to $714,000.
    • Strategic Asset Monetization: The Company completed the sale of its Plano, TX facility, for $9.5 million, contributing to $12.88 million in cash from investing activities during the quarter.
    • Debt Reduction and Capital Discipline: DSS used proceeds from asset sales and investments to pay down over $8 million in total debt, reflecting a clear commitment to balance sheet optimization.
    • Strengthening Shareholder Equity: Through its partner company Impact BioMedical, DSS raised $1.5 million in new equity capital during Q1.
    • Improved Operating Cash Flow: Net cash used in operations improved from $2.15 million in Q1 2024 to $1.64 million in Q1 2025, underscoring early operational efficiencies.

    "These results show clear, measurable progress in the financial realignment strategy we launched earlier this year," said Jason Grady, CEO of DSS, Inc. "In my January letter to shareholders, I outlined the urgent need to cut inefficiencies, strengthen our balance sheet, and lay the groundwork for sustained growth. This quarter proves that work is paying off. As we continue to streamline operations, we're now turning our attention toward execution in our core verticals and identifying smart, accretive opportunities that will drive long-term value. The foundation is in place and now we're building on it."

    The Company plans to continue to showcase measurable results from initiatives in development, operations, and M&A activity as the year progresses. With a renewed focus on high-potential business units and capital allocation, DSS is positioning itself for a dynamic second half of 2025 and beyond.

    To read the 2025 CEO shareholder letter, visit: investors.dssworld.com

    Forward-looking Statements:

    The foregoing material may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding the Company's product development and business prospects, and can be identified by the use of words such as "may," "will," "expect," "project," "estimate," "anticipate," "plan," "believe," "potential," "should," "continue" or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

    About DSS, Inc.:

    DSS, Inc. (NYSE:DSS) is a multinational company operating businesses across multiple high-growth sectors. DSS focuses on creating, acquiring, and investing in innovative companies that drive sustainable value for its shareholders.

    For investor and media inquiries or additional information, please contact:

    DSS, Inc. Investor Relations

    Email: [email protected]

    Phone: +1 (585) 565-2422



    Primary Logo

    Get the next $DSS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DSS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DSS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth

      NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating across diverse industries including packaging, real estate, and biomedical innovation, today announced financial results for the first quarter of 2025, highlighting meaningful progress in its financial repositioning and a strong foundation for corporate execution in the coming quarters. In a quarter focused on streamlining operations and financial discipline, DSS delivered significant improvements in key financial metrics: 28% Year-Over-Year Revenue Growth: Total revenues rose sharply, fueled by a 30% increase in printed product sales and a nearly doubling of rental income from the

      5/22/25 8:31:00 AM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities Offerings

      NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sentinel Brokers Company, Inc. ("Sentinel"), a FINRA-registered broker-dealer and a subsidiary of DSS, Inc. (NYSE:DSS), is pleased to announce that it has received approval from the Financial Industry Regulatory Authority (FINRA) to act as an underwriter and selling group member for corporate securities offerings. This regulatory milestone significantly enhances Sentinel's capabilities in the capital markets, enabling the firm to participate more fully in initial public offerings (IPOs), follow-on offerings, and a wide array of corporate financing transactions. The approval underscores Sentinel's strategic growth and positions the company to be

      4/24/25 8:30:00 AM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

      ROCHESTER, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company focused on innovation-driven business models, today announced the sale of its Celios® air purification asset to Impact BioMedical Inc. (NYSE:IBO) in a strategic, all-equity transaction valued at approximately $1.15 million. This divestiture aligns with DSS' ongoing strategy to optimize its portfolio and concentrate on core growth areas. Celios® is a cutting-edge air purification technology featuring a patented three-stage filtration system capable of removing ultrafine particles as small as ten (10) nanometers, helping to improve indoor air quality and mitigate airborne health risks. The sale

      2/26/25 8:30:00 AM ET
      $DSS
      $IBO
      Containers/Packaging
      Consumer Discretionary
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DSS
    Financials

    Live finance-specific insights

    See more

    $DSS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $DSS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $DSS
    SEC Filings

    See more

    $DSS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market

      NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS, "Company"))), a multinational company operating across four distinct market sectors, announced today a significant investment by its Chairman of the Board, Heng Fai Ambrose Chan. In a strategic move to bolster shareholder confidence and underscore his commitment to the company's growth. Chairman Chan acquired an additional 672,173 shares of DS, Inc. in an open market transaction on December 28, 2023.  Frank Heuszel, CEO of DSS, Inc., expressed his enthusiasm for Mr. Chan's increased stake, viewing it as a strong vote of confidence in the company's strategic direction and future potential. Heuszel said, "Chairman Chan's decis

      1/4/24 8:15:00 AM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan

      NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS, "Company"))), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, today announced that it will proceed with a 1-for-20 reverse stock split (the "Reverse Split") of its issued and outstanding shares of common stock, par value $0.02, following authorization by its Board of Directors and majority shareholders to effect a reverse split by a ratio of not less than 1-for-20 and not more than 1-for-40 (the "Reverse Split Range"), at any time on or before April 20, 2024, with the Board having the discre

      12/22/23 4:30:00 PM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years

      NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that its wholly-owned subsidiary, Premier Packaging, signed a contract extension with an existing client for the next three years totaling a minimum of $12 Million with a fourth year extension option bringing the potential total revenue to over $15 Million. Frank D. Heuszel, President and CEO of DSS, Inc., said, "We are very pleased to see that our capital investment to increase production capacity and economies of scale at

      11/28/23 8:10:00 AM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • Chan Heng Fai Ambrose bought $98,137 worth of shares (672,173 units at $0.15), increasing direct ownership by 4% to 19,586,499 units (SEC Form 4)

      4 - DSS, INC. (0000771999) (Issuer)

      1/2/24 9:10:36 AM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by DSS Inc.

      SC 13D/A - DSS, INC. (0000771999) (Subject)

      12/12/24 9:56:52 PM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • SEC Form SC 13D/A filed by DSS Inc. (Amendment)

      SC 13D/A - DSS, INC. (0000771999) (Filed by)

      5/11/23 4:30:23 PM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • SEC Form SC 13D/A filed by DSS Inc. (Amendment)

      SC 13D/A - DSS, INC. (0000771999) (Subject)

      7/15/22 7:55:49 AM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • SEC Form 10-Q filed by DSS Inc.

      10-Q - DSS, INC. (0000771999) (Filer)

      5/15/25 2:06:57 PM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • SEC Form 10-K filed by DSS Inc.

      10-K - DSS, INC. (0000771999) (Filer)

      3/31/25 1:16:35 PM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • DSS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

      8-K - DSS, INC. (0000771999) (Filer)

      2/6/25 5:09:31 PM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • Director Chan Heng Fai Ambrose was granted 1,000,000 shares (SEC Form 4)

      4 - DSS, INC. (0000771999) (Issuer)

      2/10/25 6:14:34 PM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • Wu William Wai Leung sold $19,784 worth of shares (151,020 units at $0.13), closing all direct ownership in the company (SEC Form 4)

      4 - DSS, INC. (0000771999) (Issuer)

      1/2/24 4:15:33 PM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • Chan Heng Fai Ambrose bought $98,137 worth of shares (672,173 units at $0.15), increasing direct ownership by 4% to 19,586,499 units (SEC Form 4)

      4 - DSS, INC. (0000771999) (Issuer)

      1/2/24 9:10:36 AM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary

    $DSS
    Leadership Updates

    Live Leadership Updates

    See more
    • DSS, Inc. Issues Letter to Shareholders

      NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) a multinational company operating businesses within diversified market sectors that strategically acquires and develops assets to increase shareholder value, today issued the following letter to shareholders: Dear Esteemed Shareholders, I am pleased to provide you with significant updates regarding the leadership of DSS, Inc. and to outline the strategic direction we are pursuing as a Company. It is with great honor that I announce my appointment as Interim Chief Executive Officer of DSS, Inc., effective August 23, 2024. With over 25 years of experience in leadership roles across diverse sectors—ranging from Chief Operatin

      2/3/25 8:50:17 AM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • DSS, Inc. Names Jason Grady as Interim Chief Executive Officer

      NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) has announced the appointment of Jason Grady as its Interim CEO, effective August 23, 2024. Grady, who previously served as Chief Operating Officer of DSS, Inc., brings over 25 years of extensive experience in executive leadership, business development, restructuring, and operations management across a variety of industries. He will succeed Frank D. Heuszel, who is exiting the company to transition to a leadership role within one of its former subsidiaries. Throughout his career, Mr. Grady has held pivotal positions within DSS, including CEO and Director of DSS Biohealth Holdings, President of Premier Packaging Corporation,

      8/26/24 4:08:00 PM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary
    • DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.

      ROCHESTER, N.Y., July 05, 2023 (GLOBE NEWSWIRE) -- DSS Wealth, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce the appointment of Daniel Lew as Chief Investment Officer and Portfolio Manager. With over three decades of experience in investment management, security analysis, and institutional client advisory, Mr. Lew brings a wealth of knowledge and expertise to his new role. Mr. Lew's distinguished career spans various prestigious financial institutions, where he has held senior investment management positions. Prior to joining DSS Wealth, Inc., he served as a key contributor at AIG SunAmerica, Strong Capital, John Hs

      7/5/23 8:15:00 AM ET
      $DSS
      Containers/Packaging
      Consumer Discretionary